Compare OCG & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCG | MASS |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 324.4M |
| IPO Year | 2020 | 2020 |
| Metric | OCG | MASS |
|---|---|---|
| Price | $0.23 | $5.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | ★ 19.9M | 361.8K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $316,807.00 | ★ $65,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.21 |
| 52 Week Low | $0.20 | $1.81 |
| 52 Week High | $19.29 | $9.34 |
| Indicator | OCG | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 39.13 |
| Support Level | $2.60 | $6.26 |
| Resistance Level | $19.29 | $6.83 |
| Average True Range (ATR) | 2.72 | 0.39 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 0.09 | 7.94 |
Oriental Culture Holding Ltd is an online provider of collectibles and artwork e-commerce services. The company also offers online and offline integrated marketing, storage, and technical maintenance services to customers. The company operates through one segment, namely, e-commerce of artwork trading. It generates revenue through listing service fees, transaction fees, and other revenues collected from traders.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.